Agilent Technologies, Inc. $A Stock Sold by Dudley & Shanley Inc.

Dudley & Shanley Inc. cut its holdings in Agilent Technologies, Inc. (NYSE:A) by 7.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 64,550 shares of the medical research company’s stock after selling 4,950 shares during the period. Agilent Technologies accounts for 1.8% of Dudley & Shanley Inc.’s holdings, making the stock its 23rd biggest holding. Dudley & Shanley Inc.’s holdings in Agilent Technologies were worth $11,123,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Bank of Nova Scotia purchased a new stake in Agilent Technologies in the 2nd quarter worth $58,539,000. BIP Wealth LLC purchased a new position in shares of Agilent Technologies during the second quarter valued at about $834,000. Capricorn Fund Managers Ltd bought a new stake in shares of Agilent Technologies in the first quarter worth about $8,161,000. KBC Group NV lifted its position in shares of Agilent Technologies by 18.4% in the second quarter. KBC Group NV now owns 81,883 shares of the medical research company’s stock worth $10,877,000 after buying an additional 12,719 shares in the last quarter. Finally, Sivia Capital Partners LLC purchased a new stake in shares of Agilent Technologies in the second quarter worth about $1,818,000. 87.41% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Sanford C. Bernstein lifted their price objective on Agilent Technologies from $155.00 to $180.00 and gave the stock an “outperform” rating in a research note on Thursday, August 27th. Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, September 11th. JPMorgan Chase & Co. upped their price target on shares of Agilent Technologies from $180.00 to $190.00 and gave the company an “overweight” rating in a research note on Thursday, August 27th. UBS Group started coverage on shares of Agilent Technologies in a research report on Wednesday, September 9th. They set a “neutral” rating and a $165.00 price objective for the company. Finally, Piper Sandler began coverage on shares of Agilent Technologies in a research note on Thursday, June 11th. They issued a “neutral” rating and a $150.00 price objective for the company. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $170.33.

Agilent Technologies Trading Down 0.9%

NYSE:A traded down $1.51 during midday trading on Tuesday, hitting $169.78. 815,283 shares of the company traded hands, compared to its average volume of 2,268,738. The firm has a market capitalization of $47.87 billion, a P/E ratio of 33.39, a P/E/G ratio of 2.55 and a beta of 1.21. The firm’s fifty day moving average is $153.46 and its 200-day moving average is $133.97. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $177.05. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. The business had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The business’s revenue was up 8.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, sell-side analysts predict that Agilent Technologies, Inc. will post 6.2 EPS for the current year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th will be given a $0.2550 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, October 6th. Agilent Technologies’s dividend payout ratio is 20.08%.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the business’s stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the transaction, the director owned 4,924 shares in the company, valued at $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.17% of the stock is currently owned by insiders.

About Agilent Technologies

Agilent Technologies, Inc is an analytical measurement and laboratory technology company serving the life sciences, diagnostics, pharmaceutical, chemical, environmental, food, energy and academic research markets. Its solutions help laboratories analyze the composition, quality and performance of materials, biological samples and other substances.

The company’s products and services include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy equipment, laboratory automation tools, software, consumables and supplies.